These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11742857)
1. ApoA-II versus ApoA-I: two for one is not always a good deal. Castellani LW; Lusis AJ Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1870-2. PubMed ID: 11742857 [No Abstract] [Full Text] [Related]
2. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
3. Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association. Holvoet P; Zhao Z; Deridder E; Dhoest A; Collen D J Biol Chem; 1996 Aug; 271(32):19395-401. PubMed ID: 8702626 [TBL] [Abstract][Full Text] [Related]
4. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. Hedrick CC; Castellani LW; Wong H; Lusis AJ J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828 [TBL] [Abstract][Full Text] [Related]
5. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha. Qin S; Liu T; Kamanna VS; Kashyap ML Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455 [TBL] [Abstract][Full Text] [Related]
6. Lp A-I and niacin: new views of an antiatherogenic duo. Saucan L; Brinton EA Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1707-9. PubMed ID: 11701453 [No Abstract] [Full Text] [Related]
7. Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids. Provost PR; Boucher E; Tremblay Y J Endocrinol; 2009 Mar; 200(3):321-30. PubMed ID: 19106236 [TBL] [Abstract][Full Text] [Related]
8. Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles. Wróblewska M; Kortas-Stempak B; Szutowicz A; Badzio T J Lipid Res; 2009 Apr; 50(4):667-75. PubMed ID: 19066403 [TBL] [Abstract][Full Text] [Related]
9. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids. Gao D; Podrez EA Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo. Rotllan N; Ribas V; Calpe-Berdiel L; Martín-Campos JM; Blanco-Vaca F; Escolà-Gil JC Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):e128-32. PubMed ID: 15994442 [TBL] [Abstract][Full Text] [Related]
11. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency. Chroni A; Duka A; Kan HY; Liu T; Zannis VI Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952 [TBL] [Abstract][Full Text] [Related]
12. ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity. Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Lundbom N; Lundbom J; Hakkarainen A; Aho S; Simoneau-Robin I; Taskinen MR J Clin Endocrinol Metab; 2016 Apr; 101(4):1398-406. PubMed ID: 26835543 [TBL] [Abstract][Full Text] [Related]
13. Remodelling of high density lipoproteins by plasma factors. Rye KA; Clay MA; Barter PJ Atherosclerosis; 1999 Aug; 145(2):227-38. PubMed ID: 10488948 [TBL] [Abstract][Full Text] [Related]
14. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice. Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988 [TBL] [Abstract][Full Text] [Related]
15. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. Pankhurst G; Wang XL; Wilcken DE; Baernthaler G; Panzenböck U; Raftery M; Stocker R J Lipid Res; 2003 Feb; 44(2):349-55. PubMed ID: 12576517 [TBL] [Abstract][Full Text] [Related]
16. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618 [TBL] [Abstract][Full Text] [Related]
17. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Castellani LW; Goto AM; Lusis AJ Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I. Yamato K; Tamasawa N; Murakami H; Matsui J; Tanabe J; Suda T; Yasujima M Diabetes Res Clin Pract; 2005 Aug; 69(2):124-8. PubMed ID: 16005361 [TBL] [Abstract][Full Text] [Related]
19. Expression of apolipoprotein A-I and A-II in rainbow trout reproductive tract and their possible role in antibacterial defence. Dietrich MA; Nynca J; Adamek M; Steinhagen D; Karol H; Ciereszko A Fish Shellfish Immunol; 2015 Aug; 45(2):750-6. PubMed ID: 26044744 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]